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ABSTRACT
Background and the Purpose of the Study: Patients undergoing high-dose chemotherapy for 
hematological malignancies are susceptible to development of oral mucositis, and no effective 
modality has been reported for its prophylaxis and treatment. The aim of this study was to 
evaluate the effectiveness of zinc mouthwash on  chemotherapy-induced oral mucositis lesions. 
Methods: In this double-blind randomized trial, patients under chemotherapy for acute 
leukemia were divided into two test and control groups of 15 patients each. The groups were 
homogeneous with respect to medical history, tumor characteristics, and therapeutic details. 
The test group received 10ml 0.2% zinc sulfate mouthwash, and the control group received 
10ml 0.2% chlorhexidine gluconate mouthwash, twice a day for a period of two weeks. 
Spijkervet scale was used to grade the severity of mucositis at every other week during eight 
weeks. The severity scores were analyzed with repeated measure ANOVA using SPSS 13.0 
computer software.
Results: Mean severity scores were generally lower in the test group compared to the controls at 
all four time intervals evaluated; but only, the differences in weeks of 2 and 3 were statistically 
significant (P=0.025).
Conclusion: Zinc mouthwash used in conjunction with chemotherapy may reduce the severity 
of oral mucositis lesions in patients with leukaemia. 
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INTRODUCTION
Oral mucositis is a condition characterized by 
damages to the epithelium of the oral cavity, 
pharynx, and gastrointestinal tract from chemical 
irritations, radiation therapy, or chemotherapy for 
a  hematological  malignancy  (1).  Many  protocols 
have been proposed to prevent or reduce the severity 
of oral mucositis, but no treatment modality is yet 
known to be a definite prophylactic agent (2). 
Although chlorhexidine gluconate mouthwash is 
traditionally used in patients with oral mucositis, 
there is little evidence to recommend it as a gold 
standard. While some reports indicate positive 
effects of chlorhexidine mouth rinse on oral 
mucositis, recent studies have found either no effect 
or even negative effects (3). The bitter taste, dental 
pigmentation, dysgeusia, and unpleasant sensation 
experienced together with ineffectiveness provide 
sufficient reasons for recommending an alternative 
to  the  chlorhexidine  mouthwash  (4).  Among 
medications with wound healing effects, zinc 
sulphate seems to be one of the promising agents in 
mucositis prevention (5). Zinc is an essential cofactor 
in various cellular processes such as DNA synthesis, 
RNA polymerase and reverse transcriptase, and has 
effects on wound healing, growth and immunity. The 
growth and reproductive effects of zinc are related to 
its influences on DNA synthesis, protein synthesis, 
and cell division (6). 
Considering the effects of zinc on re-epithelialization 
and wound healing, the aim of this study was to 
evaluate the effectiveness of a zinc-containing 
mouthwash on chemotherapy-induced oral 
mucositis, in comparison with chlorhexidine 
gluconate mouthwash as control. 
MATERIAL AND METHODS 
In this double-blind randomized study, patients 
were selected from those with acute leukemia under 
chemotherapy in the oncology ward of Shahid Gazi 
Hospital in Tabriz, Iran. Patient data including age, 
gender, the history of chemotherapy, the dose of the 
drug, and any known allergy to mouthwashes were 
recorded by means of a questionnaire. Patients under 
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chemotherapy on the basis an established treatment 
plan for acute myeloid leukemia (Cytarabine in the 
induction phase, and Novantrone in the consolidation 
phase) were included in this study. Exclusion 
                                                   
disease with other diagnosis of malignancies or   
chemotherapy-induced oral mucositis, any oral 
ulcers and mucosistis developed before starting 
chemotherapy, known allergy to zinc-containing or 
chlorhexidine mouthwashes. All probable risks and 
                                                    
guardians. Upon inclusion in the study, subjects 
gave written informed consents. The study protocol 
was approved by the Research Ethics Committee at 
Tabriz University of Medical Sciences. 
A total of 30 patients were selected, and matched 
with respect to medical history, tumor characteristics, 
and therapeutic details. Subjects were allocated to 
experimental and control groups of 15 patients each. 
The required dilution of (0.2%) zinc sulphate and 
chlorhexidine gluconate mouthwashes were prepared 
in the department of Medicinal Chemistry, Faculty 
of Pharmacy, Tabriz University of Medical Sciences, 
Tabriz, Iran. Patients were instructed to rinse with 10 
ml of 0.2% zinc sulphate mouthwash two times par 
day for 14 days in the experimental group, and with10 
ml of 0.2% chlorhexidine mouthwash in the same 
manner in the control group. The mouthwashes were 
                                                       
investigator as well as the subjects were blinded to 
the type of the mouthwash which was administered 
to the groups by a simple random method. 
All patients were examined every other week for 
                                                    
each session was determined by recording the length 
(E) of the lesion, measured by a digital caliper, and 
its severity (K), based on local signs, according 
to the Spijkervet scale (7). Eight distinguishable 
irradiated areas of the mouth including buccal 
mucosa (left & right), soft and hard palate, dorsum 
and border of the tongue (left & right) and the 
                                                  
                                                  
                                                  
                                                
assigned to the evaluated areas, and ranged from 
0 to 16. 
Independent t-test was used to reveal any probability 
of differences between groups in the baseline. The 
mucositis score changes for the two groups during 
the four weeks were compared using the repeated 
                                                 
                                                   
13.0 computer software. 
                      
All 30 patients completed the course of study. There 
                                                     
                                                   
trend of changes in the assessed oral mucositis index 
during the course of the study were similar in both 
                                                 
                                                  
week, and then decreased in fourth week. Although 
                                                   
compared to the controls at all four time intervals 
evaluated, repeated measure ANOVA revealed that 
                                                     
2 and 3 (P=0.025). 
                                               
preliminary evidence for the effect of zinc on oral 
mucositis. Although zinc acts as an antioxidant 
which protects cell membranes against injury 
from free radicals and can be effective during 
the initiation and message generation phases of a 
mucositis lesion (5, 6), its effect during the healing 
phase is unknown. In the week 4 of the present 
                                                        
the lesions in comparison with the control. The 
                                                     
phenytoin on oral mucositis also did not eventually 
                                                     
                                                    
the prophylactic agent should be administered 
at a higher concentration or at closer intervals. 
Oral administration of the drug could also be 
considered, although it would entail the assessment 
of the serum level of the medication. 
In the present study, a lower severity of oral mucositis 
was found in the patients receiving zinc-containing 
                                                   
                                                   
also reported to improve fast in the zinc sulfate 
group in comparison to the placebo group (9). Lin 
et al. (10) have reported that zinc supplementation 
in conjunction with radiotherapy postponed the 
development of severe mucositis in patients with 
oral cancers (10). 
Chlorhexidine, as an oral rinse, has been also 
evaluated in several randomized clinical trials for 
preventing oral mucositis (4). A meta-analysis, 
however, has shown no effect for chlorhexidine 
in the prevention of mucositis in patients under 
chemotherapy and radiotherapy (2). The results 
of the present study also showed relatively higher 
scores of oral mucositis in patients receiving 
Local sign K Length E
No mucositis 0 –
White discoloration 1        1
Erythema 2 1-2 cm 2
Pseudomembranes 3 2-4 3
Ulceration 4 > 4 cm 4
         Scores of the local signs (K) and the lengths (E) of the 
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chlorhexidine mouthwash, compared to those using 
the zinc-containing mouthwash. This indicates 
that chlorhexidine may not be a suitable agent in 
the prevention of oral mucositis in predisposed 
individuals. 
In conclusion, zinc sulfate was found to be 
                                                   
induced oral mucositis and might be indicated as 
                                                                                                                                 
                                               
a therapeutic option in cancerous patients under 
chemotherapy and/or radiotherapy. These results 
                                                 
studies with larger numbers of patients.
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